Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document

The vibes are off at OpenAI

View original at theverge.com
The Verge AI - Consumer Ai Title: The vibes are off at OpenAI Date: 2026-04-08 13:47 Source: https://www.theverge.com/ai-artificial-intelligence/908513/the-vibes-are-off-at-openai <figure> <img alt="Photo collage of Sam Altman in front of the OpenAI logo." src="https://platform.theverge.com/wp-content/uploads/sites/2/c…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Executive reshufflings, discontinued projects, and other news have raised questions about OpenAI's stability and how long it may stay on top

    60% confidence
  • ChatGPT has name-brand status akin to Kleenex for tissues

    60% confidence
  • OpenAI is in a relatively precarious position

    60% confidence
  • ChatGPT has name-brand status akin to Kleenex for tissues

    60% confidence
  • OpenAI is potentially planning for an IPO later this year

    60% confidence
  • OpenAI is in a relatively precarious position despite its funding success

    60% confidence
  • Recent events have raised questions about how stable OpenAI really is and how long it may stay on top

    60% confidence

Data points we hold from this source

OpenAI · funding raised122 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com